Virginia Cancer Institute at Reynolds Crossing /ID# 221002 — Richmond, Virginia

Virginia Cancer Institute at Reynolds Crossing /ID# 221002 is a clinical research site located in Richmond, Virginia, United States 23230.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Virginia Cancer Institute at Reynolds Crossing /ID# 221002 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Myelodysplastic Syndrome (MDS).

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Richmond

Browse all research sites in Virginia · View every site in Richmond

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Virginia Cancer Institute at Reynolds Crossing /ID# 221002?

Virginia Cancer Institute at Reynolds Crossing /ID# 221002 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Virginia Cancer Institute at Reynolds Crossing /ID# 221002 conducted?

Virginia Cancer Institute at Reynolds Crossing /ID# 221002 has 1 clinical trials on record, with 1 currently active. Their work covers Myelodysplastic Syndrome (MDS).

Is Virginia Cancer Institute at Reynolds Crossing /ID# 221002 accredited by Crixeo Clinical Trials?

Virginia Cancer Institute at Reynolds Crossing /ID# 221002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Virginia Cancer Institute at Reynolds Crossing /ID# 221002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.